Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.53M.
ENTERPRISE VALUE (EV)
$2.53M
enVVeno Medical Corporation
Market Cap
$5.60M
Enterprise Value (EV)
$2.53M
Market Cap
$5.77M
Enterprise Value (EV)
$3.72M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| enVVeno Medical Corporation (NVNO) | $5.60M | $2.53M |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.77M | $3.72M |
| Lucyd, Inc (LUCY)vs › | $5.85M | $3.45M |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | $3.07M |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | $3.07M |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | $8.64M |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.98M | $17.71M |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | $3.47M |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | N/A |
Market Cap
$5.60M
Total Debt
$0.00
Cash
$3.06M
Enterprise Value
$2.53M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
